Plecanatide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePlecanatide
Drug Alias Name普卡那肽GuanilibTrulanceGCRASP-304
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHeat-stable enterotoxin receptor agonists
TargetsHeat-stable enterotoxin receptor
Therapy Area/IndicationsChronic idiopathic constipationConstipationIrritable Bowel Syndrome
Global Approved IndicationsChronic idiopathic constipationConstipation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/01/19
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSynergy Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSalix Pharmaceuticals IncZhejiang Doyin Pump Industry Co LtdSalix Pharmaceuticals +[4] 
Inactive CompaniesBausch Health Americas Inc
Active IndicationsChronic idiopathic constipationConstipation
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeA06AX07
Related LinksWikipediaDrugBankKEGG